CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ablynx N.V. Company Snapshot
Ablynx N.V. operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ablynx N.V. with three other miscellaneous service companies in Europe: Cellectis SA of France (2016 sales of 51.01 million Euro [US$54.79 million] ), Basilea Pharmaceutica Limited of Switzerland (65.04 million Swiss Francs [US$65.10 million] ), and Innate Pharma S.A. which is based in France (56.16 million Euro [US$60.32 million] ).

Sales Analysis. During the year ended December of 2016, sales at Ablynx N.V. were 85.19 million Euro (US$91.50 million). This is an increase of 9.9% versus 2015, when the company's sales were 77.54 million Euro. This was the fifth consecutive year of sales increases at Ablynx N.V. (and since 2011, sales have increased a total of 290%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ablynx N.V.
  Stock Performance Chart for Ablynx N.V.
 
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 11.76
(Figures in Euro)
1 Week 0.9%   13 Weeks -5.7%  
4 Weeks 13.0%   52 Weeks -3.4%  
 
Ablynx N.V. Key Data:
  Ticker: ABLX Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 85,187,000
(Year Ending Jan 2017).
Employees: 344
  Currency: Euro Market Cap: 715,842,090
  Fiscal Yr Ends: December Shares Outstanding: 60,870,926
  Share Type: ACTIONS ORDINAIRES Closely Held Shares: 8,291,219
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.